Noticias de ATHE_US

19/05/2026 ATHE_US — Stock Titan

In rare MSA trial, ATH434 slowed disability and swallowing decline

19/05/2026 ATHE_US — Meyka ES ← EN

¿Por qué están bajas las existencias de Alterity Therapeutics Limited (ATHE) hoy?

ATHE cayó un +0,00% a 4,27 dólares. Descubra por qué las acciones de Alterity Therapeutics Limited están cayendo hoy: realice un seguimiento de las noticias, el volumen, los aspectos técnicos y el sentimiento.

19/05/2026 ATHE_US — MarketScreener ES ← EN

Alterity Therapeutics dice que las presentaciones de datos respaldan el desarrollo de la fase tres del candidato a tratamiento para la atrofia sistémica múltiple

Alterity Therapeutics Says Data Presentations Support Phase Three Development for Multiple System Atrophy Treatment Candidate

18/05/2026 ATHE_US — MarketScreener

Alterity Therapeutics : Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy

18/05/2026 ATHE_US — The Chronicle-Journal ES ← EN

ASE Technology Holding Co., Ltd. American Depositary Shares (cada una representa (NY: ASX

ASE Technology Holding Co., Ltd. American Depositary Shares (each representing (NY: ASX

18/05/2026 ATHE_US — The Chronicle-Journal ES ← EN

ASE Technology Holding Co., Ltd. American Depositary Shares (cada una representa (NY: ASX

ASE Technology Holding Co., Ltd. American Depositary Shares (each representing (NY: ASX

18/05/2026 ATHE_US — The Chronicle-Journal ES ← EN

ASE Technology Holding Co., Ltd. American Depositary Shares (cada una representa (NY: ASX

ASE Technology Holding Co., Ltd. American Depositary Shares (each representing (NY: ASX

16/05/2026 ATHE_US — MSN

Alterity Therapeutics Limited - Depositary Receipt (ATHE) price target increased by 15.37% to 4.93

14/05/2026 ATHE_US — MSN ES ← EN

Alterity Therapeutics Limited - El precio objetivo del recibo de depósito (ATHE) aumentó un 15,37% a 4,93

Alterity Therapeutics Limited - Depositary Receipt (ATHE) price target increased by 15.37% to 4.93

14/05/2026 ATHE_US — MSN

Alterity Therapeutics Limited - Depositary Receipt (ATHE) price target increased by 15.37% to 4.93

12/05/2026 ATHE_US — Stock Titan

[6-K] ALTERITY THERAPEUTICS LTD Current Report (Foreign Issuer) | ATHE SEC Filing - Form 6-K

12/05/2026 ATHE_US — TipRanks

Alterity Therapeutics Files May 2026 Form 6-K, Releases New Corporate Presentation

11/05/2026 ATHE_US — newser.com ES ← EN

ATHE Alterity publica sus ganancias trimestrales sin revelar ingresos ni datos de EPS; Los inversores esperan más detalles. - Alertas de rumores del mercado

ATHE Alterity releases quarterly earnings with no revenue or EPS data disclosed; investors await more details. - Market Buzz Alerts

11/05/2026 ATHE_US — Newser

ATHE Alterity releases quarterly earnings with no revenue or EPS data disclosed; investors await more details. - Hot Market Picks

11/05/2026 ATHE_US — Newser

ATHE Alterity releases quarterly earnings with no revenue or EPS data disclosed; investors await more details. - Days To Cover

11/05/2026 ATHE_US — MarketScreener ES ← EN

Alterity Therapeutics anuncia una publicación que demuestra la utilidad de la resonancia magnética cuantitativa como biomarcador para la atrofia multisistémica

Alterity Therapeutics Announces Publication Demonstrating the Utility of Quantitative MRI as a Biomarker for Multiple System Atrophy

11/05/2026 ATHE_US — Newser

ATHE Alterity releases quarterly earnings with no revenue or EPS data disclosed; investors await more details. - Annual Earnings Summary

11/05/2026 ATHE_US — Yahoo Finance

Alterity Therapeutics Announces Publication Demonstrating the Utility of Quantitative MRI as a Biomarker for Multiple System Atrophy

11/05/2026 ATHE_US — Stock Titan

MRI scan tracks brain iron to distinguish MSA from Parkinson’s

11/05/2026 ATHE_US — Newser

ATHE Alterity releases quarterly earnings with no revenue or EPS data disclosed; investors await more details.

Por favor ingresá al menos dos caracteres

Noticias del mercado